|
1
|
Wang Y, Ma Y, Fang Y, Wu S, Liu L, Fu D
and Shen X: Regulatory T cell: A protection for tumor cells. J Cell
Mol Med. 16:425–436. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. Ca Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang Y, Fu D, Tang WQ, Cai Y, Ma D, Wang
HJ, Xue RY, Liu TT, Huang XW, Dong L, et al: Ubiquitin C-terminal
hydrolase 37, a novel predictor for hepatocellular carcinoma
recurrence, promotes cell migration and invasion via interacting
and deubiquitinating PRP19. Biochim Biophys Acta. 1833:559–572.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen YJ, Ma YS, Fang Y, Wang Y, Fu D and
Shen XZ: Power and promise of ubiquitin carboxyl-terminal hydrolase
37 as a target of cancer therapy. Asian Pac J Cancer Prev.
14:2173–2179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu LL, Fu D, Ma Y and Shen XZ: The power
and the promise of liver cancer stem cell markers. Stem Cells Dev.
20:2023–2030. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hou LK, Ma YS, Han Y, Lu GX, Luo P, Chang
ZY, Xie RT, Yang HQ, Chai L, Cai MX, et al: Association of
microRNA-33a molecular signature with non-small cell lung cancer
diagnosis and prognosis after chemotherapy. PLoS One.
12:e01704312017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cho WC: OncomiRs: The discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jay C, Nemunaitis J, Chen P, Fulgham P and
Tong AW: miRNA profiling for diagnosis and prognosis of human
cancer. DNA Cell Biol. 26:293–300. 1007. View Article : Google Scholar
|
|
12
|
Wu W, Yang J, Feng X, Wang H, Ye S, Yang
P, Tan W, Wei G and Zhou Y: MicroRNA-32 (miR-32) regulates
phosphatase and tensin homologue (PTEN) expression and promotes
growth, migration, and invasion in colorectal carcinoma cells. Mol
Cancer. 12:302013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang Y, Fu D and Shen XZ: The potential
role of ubiquitin C-terminal hydrolases in oncogenesis. Biochim
Biophys Acta. 1806:1–6. 2010.PubMed/NCBI
|
|
14
|
Jalava SE, Urbanucci A, Latonen L,
Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL
and Visakorpi T: Androgen-regulated miR-32 targets BTG2 and is
overexpressed in castration-resistant prostate cancer. Oncogene.
31:4460–4471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bai Y, Wang YL, Yao WJ, Guo L, Xi HF, Li
SY and Zhao BS: Expression of miR-32 in human non-small cell lung
cancer and its correlation with tumor progression and patient
survival. Int J Clin Exp Pathol. 8:824–829. 2015.PubMed/NCBI
|
|
16
|
Xu JQ, Zhang WB, Wan R and Yang YQ:
MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion
by targeting Sox9. Tumor Biol. 35:9847–953. 2014. View Article : Google Scholar
|
|
17
|
Zhang J, Kuai X, Song M, Chen X, Yu Z,
Zhang H and Mao Z: microRNA32 inhibits the proliferation and
invasion of the SGC-7901 gastric cancer cell line in vitro. Oncol
Lett. 7:270–274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang D, Ni Z and Xu X: Decreased
microRNA-32 in oral squamous cell carcinoma. Med Sci Monit.
20:2527–2535. 2014.PubMed/NCBI
|
|
19
|
Yan SY, Chen MM, Li GM, Wang YQ and Fan
JG: miR-32 induces cell proliferation, migration, and invasion in
hepatocellular carcinoma by targeting PTEN. Tumor Biol.
36:4747–4755. 2015. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang Y, Mu J, Ma Y, Ma D, Fu D and Shen X:
The interaction between ubiquitin C-terminal hydrolase 37 and
glucose-regulated protein 78 in hepatocellular carcinoma. Mol Cell
Biochem. 359:59–66. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma YS, Wu TM, Lv ZW, Lu GX, Cong XL, Xie
RT, Yang HQ, Chang ZY, Sun R, Chai L, et al: High expression of
miR-105-1 positively correlates with clinical prognosis of
hepatocellular carcinoma by targeting oncogene NCOA1. Oncotarget.
8:11896–11905. 2017.PubMed/NCBI
|
|
23
|
Wu SD, Ma YS, Fang Y, Liu LL, Fu D and
Shen XZ: Role of the microenvironment in hepatocellular carcinoma
development and progression. Cancer Treat Rev. 38:218–225. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ge S and Huang D: Systemic therapies for
hepatocellular carcinoma. Drug Discov Ther. 9:352–362. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bartels CL and Tsongalis GJ: MicroRNAs:
Novel biomarkers for human cancer. Ann Biol Clin (Paris).
68:263–272. 2010.(In French). PubMed/NCBI
|
|
26
|
Ma Y, Hou L, Yu F, Lu G, Qin S, Xie R,
Yang H, Wu T, Luo P, Chai L, et al: Incidence and physiological
mechanism of carboplatin-induced electrolyte abnormality among
patients with non-small cell lung cancer. Oncotarget.
8:18417–18423. 2017.PubMed/NCBI
|
|
27
|
Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY,
Zhang JF, Shen HB, Zhang CY and Zen K: Serum microRNA profiles
serve as novel biomarkers for HBV infection and diagnosis of
HBV-positive hepatocarcinoma. Cancer Res. 70:9798–9807. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sukata T, Sumida K, Kushida M, Ogata K,
Miyata K, Yabushita S and Uwagawa S: Circulating microRNAs,
possible indicators of progress of rat hepatocarcinogenesis from
early stages. Toxicol Lett. 200:46–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pineau P, Volinia S, McJunkin K, Marchio
A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM and
Dejean A: miR-221 overexpression contributes to liver
tumorigebesis. Proc Natl Acad Sci USA. 107:pp. 264–269. 2010;
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Zhu Y, Ma Y, Wang J, Zhang F, Xia
Q and Fu D: The role of cancer stem cells in cancer metastasis: New
perspective and progress. Cancer Epidemiol. 37:60–63. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu D, Chen H, Yang X, Chen W, Wang L, Xu
J and Yu L: miR-32 functions as a tumor suppressor and directly
targets SOX9 in human non-small cell lung cancer. Onco Targets
Ther. 8:1773–1783. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu W, Yang P, Feng X, Wang H, Qiu Y, Tian
T, He Y, Yu C, Yang J, Ye S and Zhou Y: The relationship between
and clinical significance of MicroRNA-32 and phosphatase and tensin
homologue expression in colorectal cancer. Genes Chromosomes
Cancer. 52:1133–1140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang H, Xu T, Jiang Y, Xu H, Yan Y, Fu D
and Chen J: The challenges and the promise of molecular targeted
therapy in malignant gliomas. Neoplasia. 17:239–255. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sato F, Hatano E, Kitamura K, Myomoto A,
Fujiwara T, Takizawa S, Tsuchiya S, Tsujimoto G, Uemoto S and
Shimizu K: MicroRNA profile predicts recurrence after resection in
patients with hepatocellular carcinoma within the Milan Criteria.
PLoS One. 6:e164352011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burchard J, Zhang C, Liu AM, Poon RT, Lee
NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, et al:
microRNA-122 as a regulator of mitochondrial metabolic gene network
in hepatocellular carcinoma. Mol Syst Biol. 6:4022010. View Article : Google Scholar : PubMed/NCBI
|
